Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 1, 2003, Pages 1-7

  Liu, Bin ^a,b   Hong, Jau Shyong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; STEROID;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; CADAVER; CELL ACTIVATION; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DRUG ACTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MICROGLIA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; RISK FACTOR; SIDE EFFECT; STRUCTURE ANALYSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DOPAMINE; HUMANS; INFLAMMATION; MICROGLIA; NALOXONE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE;

EID: 0037215645     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.035048     Document Type: Review

References (59)

1. Aloisi F (1999) The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv Exp Med Biol 468:123-133.
2. Araki E, Forster C, Dubinsky JM, Ross ME, and Iadecola C (2001) Cyclooxygenase-2 inhibitor NS-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke 32:2370-2375.
3. Barron KD (1995) The microglial cell. A historical review. J Neurol Sci 134:57-68.
4. Boje KM and Arora PK (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587:250-256.
5. Bronstein DM, Perez-Otano I, Sun V, Mullis-Sawin SB, Chan J, Wu GC, Hudson PM, Kong LY, Hong JS, and McMillian MK (1995) Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res 704:112-116.
6. Brown DR (2001) Microglia and prion disease. Microsc Res Tech 54:71-80.
7. Casals J, Elizan TS, and Yahr WH (1998) Postencephalitic parkinsonism. J Neural Transm 105:645-676.
8. Castano A, Herrera AJ, Cano J, and Machado A (1998) Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 70:1584-1592.
9. Castano A, Herrera AJ, Cano J, and Machado A (2002) The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone and not mimicked by rh-TNF-α, IL-1β and IFN-γ. J Neurochem 81:150-157.
10. Chang RC, Chen W, Hudson P, Wilson B, Han DS, and Hong JS (2001) Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS. J Neurochem 76:1042-1049.
11. Chang RC, Hudson P, Wilson B, Liu B, Abel H, Hemperly J, and Hong JS (2000a) Immune modulatory effects of neural cell adhesion molecules on lipopolysaccharide-induced nitric oxide production by cultured glia. Brain Res Mol Brain Res 81:197-201.
12. Chang RC, Rota C, Glover RE, Mason RP, and Hong JS (2000b) A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: A study by electron paramagnetic resonance spectroscopy. Brain Res 854:224-229.
13. Chao CC, Hu S, Ehrlich L, and Peterson PK (1995) Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9:355-365.
14. Chao CC, Hu S, Molitor TW, Shaskan EG, and Peterson PK (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149:2736-2741.
15. Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, and Isacson O (2002) Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci 15:991-998.
16. Cuadros MA and Navascues J (1998) The origin and differentiation of microglial cells during development. Prog Neurobiol 56:173-189.
17. del Rio-Hortega P (1932) Microglia, in Cytology and Cellular Pathology of the Nervous System (Penfield W ed) pp 482-534, Paul P. Hocker, New York.
18. 5]-enkephalin on interleukin-1β secretion from microglia in mixed brain cell cultures. J Neuroimmunol 62:9-17.
19. Dehmer T, Lindenau J, Haid S, Dichgans J, and Schulz JB (2000) Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem 74:2213-2216.
20. Dickson DW, Lee SC, Mattiace LA, Yen SH, and Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
21. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, et al. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98:14669-14674.
22. Factor SA, Sanchez-Ramos J, and Weiner WJ (1988) Trauma as an etiology of parkinsonism: A historical review of the concept. Mov Disord 3:30 -36.
23. Gao HM, Hong JS, Zhang WQ, and Liu B (2002a) Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 22:782-790.
24. Gao HM, Jiang J, Wilson B, Zhang WQ, Hong JS, and Liu B (2002b) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson's disease. J Neurochem 81:1285-1297.
25. Greenamyre JT, MacKenzie GM, Peng T-I, and Stephans SE (1999) Mitochondrial dysfunction in Parkinson's disease. Biochem Soc Symp 66:85-97.
26. Hoffmann JA, Kafatos FC, Janeway CA, and Ezekowitz RA (1999) Phylogenetic perspectives in innate immunity. Science (Wash DC) 284:1313-1318.
27. Hoozemans JJ, Rozemuller AJ, Veerhuis R, and Eikelenboom P (2001) Aspects of Alzheimer's disease: Therapeutic implications. Bio Drugs 5:325-337.
28. Hsu HY and Wen MH (2002) Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of IL-1 gene expression. J Biol Chem 277:22131-22139.
29. Iravani MM, Kashefi K, Mander P, Rose S, and Jenner P (2002) Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110:49-58.
30. Itzhak Y, Martin JL, and Ali SF (1999) Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Synapse 34:305-312.
31. Jeohn G-H, Kong L-Y, Wilson B, Hudson P, and Hong J-S (1998) Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10.
32. Kang J, Park EJ, Jou I, Kim JH, and Joe EH (2001) Reactive oxygen species mediate Aβ(25-35)-induced activation of BV-2 microglia. Neuroreport 12:1449-1452.
33. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, and Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia. J Neurosci 20:6309-6316.
34. Kong LY, McMillian MK, Hudson PM, Jin L, and Hong JS (1997) Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther 280:61-66.
35. Kreutzberg GW (1996) Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
36. Lawson LJ, Perry VH, Dri P, and Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151-170.
37. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, and Przedborski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403-1409.
38. Ling Z, Gayle DA, Ma SY, Lipton JW, Tong CW, Hong JS, and Carvey PM (2002) In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 17:116-124.
39. Liu B, Du L, and Hong JS (2000a) Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Phar Exp Ther 293:607-617.
40. Liu B, Du L, Kong LY, Hudson PM, Wilson BC, Chang RC, Abel HH, and Hong JS (2000b) Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 97:749-756.
41. Liu B, Gao HM, Wang J-Y, Jeohn G-H, Cooper CL, and Hong JS (2002c) Role of nitric oxide in inflammation-mediated neurodegeneration. Ann NY Acad Sci 962:256-263.
42. Liu B, Jiang JW, Wilson B, Du L, Yang SN, Wang JY, Wu GC, Cao XD, and Hong JS (2000d) Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther 295:125-132.
43. Liu Y-X, Qin L, Wilson BC, An L, Hong JS, and Liu B (2002) Inhibition by naloxone stereoisomers of β-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J Pharmacol Exp Ther 302:1212-1219.
44. Lipsky PE (1999) The clinical potential of cyclooxygenase-2 -specific inhibitors. Am J Med 106:51S-57S.
45. Lu X, Bing G, and Hagg T (2000) Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Neuroscience 97:285-291.
46. McGeer PL, Itagaki S, Boyes BE, and McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285-1291.
47. McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, and Carvey PM (2001) Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol 169:219-230.
48. McMillian MK, Thai L, Hong JS, O'Callaghan JP, and Pennypacker KR (1994) Brain injury in a dish: A model for reactive gliosis. Trends Neurosci 17:138-142.
49. Olanow CW and Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123-144.
50. Qin L, Liu YX, Cooper CL, Liu B, Wilson B, and Hong JS (2002) The role of microglia in β-amyloid (1-42) toxicity to cortical and mesencephalic neurons. J Neurochem, in press.
51. Raine CS (1994) Multiple sclerosis: Immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 53:328-337.
52. Rogers J, Luber-Narod J, Styren SD, and Civin WH (1988) Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9:339-349.
53. Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB Jr, Ritchie TC, Hunninghake GW, Zandi E, and Engelhardt JF (2001) Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-κB. J Biol Chem 276:30188-31098.
54. Simpkins CO, Ives N, Tate E, and Johnson M (1985) Naloxone inhibits superoxide release from human neutrophils. Life Sci 37:1381-1386.
55. Stoll G, Jander S, and Schroeter M (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56:149-171.
56. Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, and Mullan M (1999) Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation. Science (Wash DC) 286:2352-2355.
57. Vallance P, Collier J, and Bhagat K (1997) Infection, inflammation and infarction: Does acute endothelial dysfunction provide a link? Lancet 349:1391-1392.
58. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, and Przedborski S (2002) Blockade of microglial activation is neuroprotective in the 1-methyl -4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.
59. Xie Z, Wei M, Morgan TE, Fabrizio P, Han D, Finch CE, and Longo VD (2002) Peroxynitrite mediates neurotoxicity of amyloid β-peptidel-42- and lipopolysaccharide-activated microglia. J Neurosci 22:3484-3492.